Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. F. H. Walter, F. D. Mairinger, R. Werner, S. Ting, T. Hager, C. Vollbrecht, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Koeln, Germany). mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation. Eur Respir J 2013; 42: Suppl. 57, 2925

Member's Comments

No comment yet.

Related content which might interest you: Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Molecular profiling of lung squamous carcinogenesis Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Telomere-associated gene network in lung adenocarcinoma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Development of an invasive 3D lung tumor model for oncological research Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 The proteasome subunits PSMA5 and PSMB4 are potent markers to discriminate between typical and atypical carcinoid tumors of the lung Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015